Additionally, SIRT1 catalyzes FOXK2 deacetylation, reducing tumor cell apoptosis and decreasing sensitivity to the chemotherapy drug cisplatin (Figure 4) (45). The gene discussed is FOXK2; the disease is neoplasm.